Desloratadine Production Not Anticipated In Loratadine Patent – Schering
This article was originally published in The Tan Sheet
Executive Summary
A compound does not need to be explicitly described in writing to be inherently anticipated by a patent, a Federal Circuit judge told Schering-Plough April 8